BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1976577)

  • 61. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Royal Free Hospital protocol for 24-hour intragastric acidity and plasma gastrin concentration.
    Pounder RE; Lanzon-Miller S; Smith JT; Gavey C; Nwokolo CU; Prewett EJ; Sercombe J
    Dig Dis; 1990; 8 Suppl 1():10-7. PubMed ID: 2225513
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibitory effect of somatostatin on gastric acid secretion and serum gastrin in dogs with and without duodenogastric reflux.
    Thomas WE
    Gut; 1980 Nov; 21(11):996-1001. PubMed ID: 6108902
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of the H2-antagonists on histamine action and interaction with gastrin in isolated parietal cells.
    Soll AH
    Gastroenterology; 1978 Feb; 74(2 Pt 2):355. PubMed ID: 23337
    [No Abstract]   [Full Text] [Related]  

  • 66. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
    Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
    Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regular use of H2 blockers reduces the efficacy of roxatidine to control gastric pH and volume.
    Hirota K; Kudo M; Kushikata T; Hashimoto H; Matsuki A
    Can J Anaesth; 2005 Feb; 52(2):166-71. PubMed ID: 15684257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?
    Hashimoto H; Kushikata T; Kudo M; Hirota K
    J Gastroenterol; 2007 Apr; 42(4):275-8. PubMed ID: 17464455
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Do ranitidine and nizatidine influence pepsin secretion?
    Vianello F; Tessaro P; Di Mario F; Dal Santo PL; Vio A; Plebani M; Burlina A; Naccarato R
    Acta Gastroenterol Belg; 1988; 51(2):154-8. PubMed ID: 2906777
    [No Abstract]   [Full Text] [Related]  

  • 70. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.
    Richardson CT; Feldman M; Brater C; Welborn J
    Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulation of expression of the receptors controlling gastric acidity.
    Kolivas S; Shulkes A
    Regul Pept; 2004 Sep; 121(1-3):1-9. PubMed ID: 15256267
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum gastrin and gastric acid secretion at high altitude.
    Jó N; García O; Jara R; Garmendia F; Nago A; García R; Hidalgo H; Flores L
    Horm Metab Res; 1987 Apr; 19(4):182-3. PubMed ID: 3583225
    [No Abstract]   [Full Text] [Related]  

  • 73. Rebound nocturnal hypersecretion after H2-receptor antagonist.
    Savarino V; Mela GS
    Gut; 1989 Sep; 30(9):1300-2. PubMed ID: 2572518
    [No Abstract]   [Full Text] [Related]  

  • 74. Preoperative H2-receptor antagonists.
    Gorback MS
    Anesth Analg; 1990 Aug; 71(2):205-6. PubMed ID: 1973883
    [No Abstract]   [Full Text] [Related]  

  • 75. Gas-liquid chromatographic resolution of some racemic synthons for lamtidine analogous histamine H2-receptor antagonists via diastereomeric amides of (1S)-(-)-camphanic acid.
    Büyüktimkin N; Keller F; Schunack W
    J Chromatogr; 1989 Apr; 467(2):402-5. PubMed ID: 2569470
    [No Abstract]   [Full Text] [Related]  

  • 76. Intragastric acidity and serum gastrin after sufotidine.
    Mela GS; Caputo E; Villa G; Savarino V; Zentilin P
    Gut; 1990 Sep; 31(9):1087-8. PubMed ID: 1976577
    [No Abstract]   [Full Text] [Related]  

  • 77. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
    Rogers MJ; Holmfield JH; Primrose JN; Johnston D
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
    Smith JT; Gavey C; Nwokolo CU; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects.
    Smith JT; Pounder RE
    Gut; 1990 Mar; 31(3):291-3. PubMed ID: 1969833
    [TBL] [Abstract][Full Text] [Related]  

  • 80. H2-receptor antagonists: intragastric acidity after repeated doses. Introduction.
    Halter F
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():1-6. PubMed ID: 1983343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.